Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study.
RSVpreF and nirsevimab may substantially reduce RSV infant hospitalisations in Japan and the benefit of the seasonal programmes depends on predictability of RSV seasonality and potential logistical challenges.